You are here
Dr. Stephen Marder, Dr. Phillip Janicak and Dr. Rajiv Tandon meet at APA 2014 to discuss new developments in schizophrenia, and gradual changes in the ethos of psychiatry.
In this panel discussion, Dr Janicak, Dr Tandon and Dr Marder talk about changes in treatment approaches towards schizophrenia. They recognise that the philosophy of psychiatry has changed, with more emphasis on treatment as being individualized, targeted, and measurement-based. More importance is now given to better functioning and a better quality of life in a broader sense, rather than only focusing on managing psychosis and negative symptoms.
- Has there been anything this year that stands out as a new development in schizophrenia?
- Dr Tandon notes the growing emphasis on broader approaches to treatment that involve tailored, targeted therapies. He cites the DSMV classification of dimensions and domains of psychopathology and how they can be used to provide measurement based care.
- Dr Marder perceives a change in the culture of psychiatry, from simply suppressing negative symptoms, towards holistically increasing quality of life
- Dr Tandon suggests that there is currently a focus on lower dosing in conjunction with non-pharmaceutical interventions
- Dr Marder reflects that the psychiatry community is not hopeful about finding a groundbreaking new antipsychotic with a new mechanism of action, and has perceived a focus on utilizing current treatments more effectively instead.